Cathepsin B-like genes from Leishmania donovani and Leishmania chagasi have been isolated and characterized. It is a single gene, which is constitutively expressed in all the life cycle stages of the parasite. Studies using cathepsin B-specific inhibitor treatment suggested that cathepsin B does not seem to play a role in the promastigote stages of the parasite, however it aids in the parasite survival within the host macrophages. Antisense mRNA inhibition of cathepsin B gene also revealed that it plays an important role in the parasite survival within the host macrophages. Furthermore, for the first time, we have shown that Leishmania whole cell lysates as well as the recombinant cathepsin B protein cleaved human recombinant latent transforming growth factor (TGF)-␤1 into a mature peptide releasing the latency associated protein, in a cell-free incubation system. Mink lung epithelial cell growth inhibition assay revealed that the cleaved TGF-␤1 was biologically active, suggesting that Leishmania cathepsin B can cleave latent TGF-␤1 into mature and active form. These results suggest that cathepsin B plays an important role in Leishmania survival within the host macrophages by activating latent TGF-␤1.
Protozoan parasites of Leishmania sp. are diploid eukaryotes, causing a variety of human diseases (1) . These organisms live alternately as extracellular promastigotes within the insect vector and as intralysosomal amastigotes in the host macrophages (2) . Among the variety of disease manifestations, visceral leishmaniasis caused by Leishmania donovani complex is fatal and is a serious health problem in many tropical and subtropical countries (3) . Leishmania parasites contain high levels of cysteine proteases, belonging to cathepsin L and cathepsin B families (4) . Cysteine proteases have been shown to play critical roles in the pathogenesis of parasitic protozoan infections (5) . Studies using CA074, a cathepsin B-specific inhibitor-treated BALB/c mice, showed resistance against Leishmania major infection and also showed the shift of immune responses from Th2 to protective Th1 type (6) . However, the mechanism by which cathepsin B affects the immune response is not known.
Studies involving species of Leishmania such as L. major and Leishmania amazonensis have been shown to induce the production of biologically active transforming growth factor ␤ (TGF-␤) 1 by macrophages upon infection (7) . L. donovani infection is known to induce the expression of a number of cytokine genes like TNF-␣, GM-CSF, TGF-␤, and IL-6. Also, susceptibility to Leishmania chagasi infection in BALB/c mice is correlated with the localized production of TGF-␤1 at the site of maximal parasite growth in the liver (8) . Application of anti-TGF-␤ antibodies arrested the development of lesions in mice, whereas treatment with TGF-␤ exacerbated the infection with L. amazonensis, Trypanosoma cruzi, and Toxoplasma gondii (9) . L. major, Leishmania mexicana, and Leishmania braziliensis trigger the production of TGF-␤ and IL-10, which inhibit killing of intracellular organisms (10) . It was also shown that TGF-␤ plays a role in limiting IFN-␥ production during the primary infection in mice (11) . IFN-␥, on the other hand, is known to induce the expression of inducible nitric-oxide synthase, the key effector mechanism for the killing of Leishmania and other parasites within the mouse macrophages, both in vitro and in vivo (12) .
TGF-␤ isoforms are synthesized as large biologically inactive precursors, which are proteolytically processed to yield mature and active homodimer. A variety of agents and treatments are known to activate latent TGF-␤, like heat, acidic pH, plasmin, subtilisin-like endopeptidases, and cathepsins (13) (14) (15) . Earlier studies have implicated the role of proteases and sialidases in the processing of host-derived latent TGF-␤ (16) . Therefore, we hypothesize that Leishmania cathepsin B enzymes cleave latent TGF-␤ into mature and active TGF-␤ and thus helps parasites to overcome the microbicidal activity of the macrophages.
In the present study, we have isolated and characterized the cathepsin B-like gene from the L. donovani complex. The functional role of cathepsin B in parasite survival using cathepsin B-specific inhibitor CA074 and antisense mRNA inhibition revealed that it plays an important role in the amastigote survival within the macrophages. Also, we have expressed the L. chagasi cathepsin B in an insect cell expression system, in its active form, and for the first time we have demonstrated that leishmanial cathepsin B can cleave latent TGF-␤ into biologically active form, using parasite whole cell extracts as well as recombinant cathepsin B protein. These results suggest that cathepsin B plays an important role in Leishmania survival within the macrophages, by activating TGF-␤.
EXPERIMENTAL PROCEDURES
Chemicals-Modified minimum essential medium (HO-MEM), M199 medium, fetal calf serum, Lipofectin, and gentamycin were obtained from Invitrogen. Tunicamycin and phorbol myristate acetate were purchased from Sigma. Protease inhibitors, E-64, CA074, and peptide substrate Z-Phe-Arg-AMC were purchased from Peptides International, Inc., Louisville, KY. Human recombinant TGF-␤1 and the neutralizing antibodies, anti-TGF-␤1, anti-LAP (latency-associated protein), and anti-mouse secondary antibody, were obtained from R & D Systems. The ECL-enhanced chemiluminescent kit and Quick-Prime labeling kits were purchased from Amersham Biosciences.
Cell Culture-L. chagasi (MHOM/BR/84, kindly provided by Dr. Mary, E. Wilson, University of Iowa) was cultured at 26°C in modified minimum essential medium (HO-MEM) supplemented with 10% heat-inactivated fetal calf serum. L. donovani (1S2D, kindly provided by Dr. Greg Matlashweshki, McGill University, Montreal, Canada) was cultured at 26°C in modified M199 medium supplemented with 10% heat-inactivated fetal calf serum. Cultures were seeded at 1 ϫ 10 6 parasites/ml and harvested at logarithmic or stationary phase of growth as defined by cell density and morphological characteristics. U937 macrophage cells were cultured in RPMI medium (Invitrogen) supplemented with 10% fetal calf serum at 37°C and in the presence of 5% CO 2 . Mv1Lu mink lung epithelial cells (CCL-64, ATCC) were cultured in RPMI medium supplemented with 10% bovine calf serum, 1% MEM nonessential amino acids, and 1 mM HEPES in the presence of 5% CO 2 , at 37°C.
Isolation of the Cathepsin B-like Gene from L. chagasi-Conserved amino acid sequence information was obtained by comparing the reported cathepsin B-like gene sequences from various organisms. A sense primer was synthesized, which included an EcoRI site (5Ј-ACA-GAATTCACGATCGGCGAGATTCGTGACC-3Ј), corresponding to the conserved amino acids 16 
TIGEIRDQ
23 in the mature domain, and the antisense primer included a HindIII site (5Ј-CGCAAGCTTGATCAA-GAAGTAGCCTTTGTC-3Ј), corresponding to the amino acids 216 DKGY-FLI 222 in the C-terminal domain of other trypanosomatid cathepsin B. These primers were used to PCR-amplify partial cathepsin B-like gene fragments from the genome of L. chagasi and L. donovani. Genomic DNA (100 ng) was used in the standard PCR reaction. The parameters used in the PCR were 30 cycles at 94°C for 1 min, 45°C for 1 min, and 72°C for 1 min. A single band of ϳ600 bp was amplified and subcloned for DNA sequencing.
To obtain full-length clone, this partial gene fragment was used as a probe to screen an L. chagasi amastigote cDNA library (kindly provided by Dr. M. E. Wilson, University of Iowa, College of Medicine, Iowa City, IA). Clones were sequenced with vector-based external primers and the internal primers derived from the partial gene fragment. The partial gene sequence of cathepsin B starting from poly(A) tail end up to the end of predicted propeptide was obtained from the positive clones. To obtain the complete gene sequence, a partial genomic library was constructed using a 4-kb PstI fragment (Fig. 1A ) in pGEM-2 plasmid and screened. Positive clones were sequenced, and predicted amino acids sequences were aligned using ClustalW provided by Bioedit sequence alignment editor program.
Nucleic Acid Preparations and Hybridization Studies-Genomic DNA was isolated from early stationary phase promastigotes of L. chagasi and L. donovani, using standard protocol (17) . For Southern analyses, 2 g of genomic DNA was digested with appropriate restriction enzymes. Digested genomic DNA samples were fractionated on 0.9% agarose gels and blotted onto Hybond Nϩ membrane.
Total RNA was isolated using TRIzol Reagent as recommended by the manufacturer. Promastigote RNA was obtained from logarithmic and stationary phase parasites. To obtain amastigote RNA, the human macrophage cell line (U937, ATCC) was infected with stationary promastigotes, which subsequently converted into intracellular amastigotes within the macrophage cells. Total RNA was isolated from the infected macrophage cells using TRIzol reagent. RNA (8 g/lane) was separated on 1.2% formaldehyde-agarose gels and transferred onto Hybond Nϩ membrane. Standard procedures were followed to perform Southern and Northern blot hybridizations (17) . Probes representing specific regions of cathepsin B were PCR-amplified from the cDNA clone or the genomic clone of L. chagasi and labeled with [␣-
32 P]dCTP, using a Quick-Prime labeling kit.
Expression of L. chagasi Cathepsin B in Insect Cells-To express active cathepsin B-like cysteine protease enzyme, the coding region was amplified by PCR from genomic DNA of L. chagasi. PCR product was digested with NotI restriction endonuclease and was cloned in-frame into unique NotI site of pIE1/153A.jhe vector (18) and confirmed by sequencing. Culture of insect cells and procurement of samples containing recombinant protein from transfected insect cells are as described earlier (19) . Briefly, High Five insect cells were seeded into six-well culture plates (35 mm diameter) at a density of 5 ϫ 10 5 cells/ml (2 ml/well) and transfected for 5 h with 0.5 ml of transfection solution containing 30 g/ml Lipofectin and 6 g/ml total plasmid DNA in basal IPL-41 medium. Then the transfection solution was removed, and the cells were rinsed with basal medium and 2 ml of IPL-41 ϩ 10% fetal bovine serum was added and incubated for 60 h. The supernatant was then harvested and stored at Ϫ20°C for analysis.
Measurement of Enzyme Activity and Inhibition Assays-Cathepsin B activity in the recombinant protein and the whole cell lysates of the parasites was assayed using the synthetic peptide substrate, Z-PheArg-amidomethylcoumarin (AMC). The assays were carried out in 96-well microtiter plates. The buffer used for the assays contained 100 mM sodium acetate, pH 5.5, 10 mM dithiothreitol, 0.1% Triton X-100, 1 mM EDTA, and 0.5% Me 2 SO. Reaction was initiated by the addition of 10 M final concentration of the substrates and incubated for 30 min at 37°C. The proteolytic activity was monitored by the appearance of 7-amino-4-methylcoumarin from the synthetic substrates. The fluorescence of the liberated 7-amino-4-methylcoumarin was measured using a Labsystem Fluoroscan II Spectrofluorometer at 460 nm emission and an excitation wavelength of 355 nm.
For inhibition studies, cathepsin B-specific inhibitor CA074 was used at a final concentration of 10 M. For in vitro inhibition studies, promastigotes of L. chagasi were cultured in HO-MEM containing 10% fetal calf serum, with or without 20 g/ml CA074 for 6 days at 26°C. The proliferation of parasites was evaluated by counting the parasites every 24 h, and whole cell lysates were prepared to assay for the enzyme activity.
Plasmid Constructs for Antisense mRNA Inhibition of Cathepsin B Gene-To generate the specific sense and antisense mRNA of cathepsin B gene, the Leishmania-specific vector P6.5, (kindly provided by Dr. K. P. Chang, Chicago Medical Center) was used. P6.5 has a pBluescript backbone along with ϳ7.5-kb Leishmania DNA (20) . The 1-kb coding region of cathepsin B was inserted at BamHI site of the P6.5 vector. The insert was cloned in both sense and antisense orientations with reference to that of a downstream N-acetylglucosamine 1-phosphate transferase gene (nagt), which is the selective marker for tunicamycin resistance. The P6.5 plasmid alone, the sense plasmid CatB-S, and antisense plasmid CatB-AS were amplified in Escherichia coli, and plasmid DNA was isolated for transfection using DNA maxi-prep kit.
Transfection of Leishmania Parasites-All the plasmid constructs were confirmed by sequencing and transfected into L. chagasi promastigotes. Briefly, 4 ϫ 10 7 log phase promastigotes were pelleted, washed twice with phosphate-buffered saline, and resuspended in 0.4 ml of electroporation buffer in a 0.2-cm cuvette. Twenty-five g of plasmid DNA of vector alone (P6.5), P6.5 with cathepsin B in correct orientation (CatB-S), and P6.5 with cathepsin B in reverse orientation (CatB-AS) were electroporated using a Bio-Rad Gene Pulser Unit at 0.45 kV, capacitance of 25 microfarads and resistance of 250 ohms. Following electroporation, cells were resuspended in drug-free medium for 24 h. Cells were then selected for tunicamycin resistance at 5, 10, and 20 g/ml concentrations. Parasites selected at 20 g/ml were used for all the analyses.
In Vitro Assay for Intramacrophage Survival and Replication-The U937 macrophage cells were infected with L. chagasi promastigotes at a host to parasite ratio of 1:10. Briefly, U937 suspension cells (10 6 cells per ml) in 10 ml of RPMI 1640 medium supplemented with 10% heatinactivated fetal bovine serum, 2 mM L-glutamine, and 50 g of gentamycin were allowed to grow at 37°C for 3 days in the presence of 5% CO 2 . The cells were counted and then seeded at the rate of 2 ϫ 10 5 cells/cm 2 area. The cells were induced to adhere with 7.5 ng/ml phorbol myristate acetate and allowed to recover for 72 h. The macrophage cells were then infected with 10 stationary phase parasites per macrophage cell and allowed to infect for 4 h. The free and unbound parasites were washed with RPMI medium, and the infected macrophage cells were fed with fresh RPMI medium and left for 4 days. Infected cells were scraped from flasks at a 24-h interval, washed with 1ϫ phosphate-buffered saline, and fixed on the microscopic slides. Slides were then stained using Diff-Quick and used for counting the intracellular amastigotes.
TGF-␤1 Immunoenzymatic Assay-Recombinant human latent TGF-␤1 was diluted in sterile 1ϫ phosphate-buffered saline. Cell-free incubations with different concentrations of either recombinant cathepsin B or the parasite whole cell lysates were carried out at 37°C for 2 h.
As a positive control, active TGF-␤1 was generated by acid activation by incubating with 2 N HCl for 10 min at room temperature. Following incubation, nonreducing 2ϫ SDS sample buffer was added to all the samples, and denaturing electrophoresis was carried out according to the standard protocol. Under this condition, mature TGF-␤1 migrates as a dimer with a molecular mass of 25 kDa.
Assay for Bioactive TGF-␤1-Bioactive TGF-␤1 was monitored using a growth inhibition assay with Mv1Lu mink lung epithelial cells, as originally described (21) . Briefly, Mv1Lu cells were plated in 96-well plates at 2,500 cells/well. After 3-h incubation, samples to assay for TGF-␤1 activity were added. After 72-h incubation, the cells were pulsed with [ 3 H]thymidine for 8 h. Medium was removed, and cells were washed with 3:1 methanol:glacial acetic acid, followed by three washes with 80% methanol. Cells were then incubated with 0.25 N NaOH and neutralized with 5 N HCl. Cell supernatant was collected in scintillation vials, and radioactivity incorporated into DNA was counted in a liquid scintillation counter.
Western Blot Analysis-Denaturing gel electrophoresis was carried out according to the standard method. Following SDS-PAGE, proteins were transferred onto to Hybond P membrane using a semidry transblot apparatus (Bio-Rad). Membranes were blocked for 2 h with 5% skim milk solution. For the detection of cathepsin B, blots were incubated overnight at 4°C with 1:2,000 dilution of anti-cathepsin B antiserum (kindly provided by Dr. Judy Sakanari, Sonoma University, Rohnert Park, CA). To detect the proregion of the TGF-␤1, the blots were incubated with anti-human LAP monoclonal antibody at a concentration of 2 g/ml, and to detect the mature TGF-␤1, anti-human TGF-␤1 monoclonal antibody was used at a concentration of 2 g/ml. Following incubation in the primary antibody, membranes were washed three times with phosphate-buffered saline containing 0.1% Tween and incubated with 1:5,000 dilution of anti-mouse or anti-rabbit horseradish peroxidase-linked secondary antibody. An enhanced chemiluminescent kit was used for protein detection.
RESULTS

Isolation of Cathepsin B-like Gene from L. chagasi and L. donovani-
To isolate the cathepsin B gene from L. chagasi, primers were designed based on the conserved amino acid sequences from various organisms. PCR reaction using these primers yielded a fragment of 600 bp. This fragment was used to hybridize a Southern blot containing genomic DNA of L. major, L. donovani, and L. chagasi, digested with different restriction enzymes. The results showed that a cathepsin B-like gene is indeed present in L. chagasi and L. donovani as a single copy gene and that the gene organization is identical in case of L. chagasi and L. donovani, but restriction sites varied in the case of L. major (Fig. 1A ). The PCR fragment was then used to screen a promastigote cDNA library of L. chagasi, and several positive clones were selected. Sequence analysis revealed that only partial coding sequences were present in the cDNA clones.
We then cloned the PstI fragment from L. chagasi (Fig. 1A , lane 6) into PGEM-2 vector and constructed a partial genomic library, to obtain the complete gene, including the 5Ј-untranslated region. Based on the sequence information of L. chagasi cathepsin B gene, primers were designed to amplify the L. donovani cathepsin B-like gene from L. donovani genome.
The full-length of L. chagasi (GenBank TM accession number AF216830) and L. donovani (GenBank TM accession number AF233525) cathepsin B genes encode a predicted protein of 340 amino acids. Sequence analysis showed that LcCatB and LdCatB are 99.7% identical to each other and 90% identical to that of LmajCatB, 66% identical to LmexCatB, and only 45% identical to human cathepsin B gene (data not shown). As in case of L. major cathepsin B, the amino acid serine 331 (Ser 331 ) is replaced by a glycine residue in case of L. donovani and L. chagasi cathepsin B, which results in low activity of leishmanial cathepsin B toward the synthetic peptide substrate, Z-Arg-Arg-AMC. However, because of this replacement, leishmanial cathepsin B can readily cleave the cathepsin L-specific synthetic substrate, Z-Phe-Arg-AMC.
Northern blot analysis revealed a transcript size of 2.4 kb, which is constitutively expressed in all the life cycle stages of the parasite (Fig. 1B, panel I ). When compared with the ␣-tubulin transcript controls (Fig. 1B, panel II) , the ratio of expression at all stages remained constant, suggesting that the cathepsin B gene might play a role in housekeeping, during the developmental stages of the parasite.
Expression of Active Cathepsin B in Insect Cells-To study the substrate specificity of the cathepsin B-like cysteine protease, the coding region of L. chagasi cathepsin B gene was cloned into pIE1/153A.jhe vector and transfected into High Five insect cells. Cathepsin B expressed as a JHE (juvenile hormone esterase) fusion protein is secreted into the medium. The supernatant was collected and analyzed for the presence of recombinant protein by Western blot analysis, using anti-JHE and anti-LmCatB antibodies. The results of the Western analysis are presented in Fig. 2A , panel I (␣-JHE antibody) and Fig.  2A, panel II (␣-LmCatB antibody) . The antibodies detected a major band of 102 kDa, corresponding to the JHE-cathepsin B fusion protein.
The recombinant protein was then assayed for the protease activity using the synthetic peptide substrate, Z-Phe-Arg-AMC. The specificity of the activity was determined by using a cathepsin B specific inhibitor, CA074. The results are tabulated in the form of bar diagram (Fig. 2B) . Results indicate that the recombinant JHE-cathepsin B fusion protein is indeed active against Z-Phe-Arg-AMC. The controls, cells, and JHE protein showed significantly low background fluorescence. The activity is specifically inhibited in presence of CA074, up to 85%. This indicates that the recombinant cathepsin B is proteolytically active, although it is fused with JHE protein.
Effect of CA074 on Cathepsin B Activity and Growth of Leishmania Parasites-To study the functional role of cathepsin B on the parasite growth and survival, we have used CA074, a cathepsin B-specific synthetic inhibitor. Growth curve analysis indicates that the inhibitor itself does not affect the growth of the parasites during the promastigote stages of the parasite (data not shown). Furthermore, inhibitor treatment did not alter the amount of cathepsin B, both in promastigote and axenically grown amastigote stages of the parasite (Fig. 3A) . However, the cathepsin B activity in parasites, which were grown in presence of CA074 showed significant reduction, when compared with that of control parasites in both the stages of development (Fig. 3B) . The activity toward Z-Phe-Arg-AMC was similar in case of promastigotes as well as in axenically cultivated amastigotes. The parasites grown in the presence of inhibitor were then used to infect the U937 macrophages, to test the effect of reduced cathepsin B activity on parasite survival. The macrophage infection data (Fig. 4) shows that the inhibitor-treated promastigotes had reduced survivability compared with untreated promastigotes, at all time points studied. Taken together the results from this study suggest that cathepsin B activity is important for Leishmania survival within the host macrophage cells, but does not play a role during the promastigote stage of the development.
Modulation of Cathepsin B Expression by Antisense mRNA Inhibition-Transfectants were selected and subsequently grew in medium with tunicamycin, up to 20 g/ml. The presence of plasmids in these transfectants was confirmed by Southern blot analysis using specific probes (data not shown). Northern blot analysis of these samples with specific PCRgenerated probes revealed that they contained sense and antisense cathepsin B transcripts. Only transfectants with the CatB-AS plasmid expressed the antisense transcripts, which concomitantly showed a decrease in the sense transcript when compared with the wild type and vector alone transcfected parasites (Fig. 5A, panel II) . Equal loading of RNA is shown by the ethidium bromide stain (Fig. 5A, panel III) . The results obtained clearly demonstrate that the presence of episomal cathepsin B antisense mRNA significantly reduces the endogenous cathepsin B mRNA.
Western blot analysis of these transfectants showed that the expression of antisense RNA affected the level of cathepsin B protein translated (Fig. 5B, panel I ). The changes in the level of cathepsin B is significant compared with those seen in the wild type parasites and those transfected with the vector alone. The Coomassie-stained gel is used to verify the equal loading of the protein extracts (Fig. 5B, panel II) . The results obtained thus indicate that antisense mRNA expression affects the translation of endogenous cathepsin B mRNA, thereby significantly reducing the cathepsin B protein in these transfectants.
Effect of Antisense mRNA Inhibition on Cathepsin B Activity and Intramacrophage Survival of Parasites-To study the effect of cathepsin B activity due to antisense mRNA inhibition on survival of parasites in the host macrophages, cathepsin B activity toward specific synthetic substrate in the transfectants was assessed using fluorogenic assay, and also the subsequent effect on intracellular survival and replication was studied using U937 macrophage-like cells. The results from the fluorogenic assay revealed that the transfectants with the antisense plasmid had significantly reduced activity toward the substrate used, Z-Phe-Arg-AMC (Fig. 6A ) when compared with that of the transfectants with sense plasmids and vector alone. Similarly, the macrophage infection data also revealed that the transfectants with the antisense plasmid showed significant reduction in the parasite survival and multiplication within the macrophage cells when compared with those with sense plasmid and vector alone (Fig. 6B) . Taken together, these results clearly suggest that cathepsin B activity is important for the parasite survival within the macrophages.
Effect of Cathepsin B on TGF-␤1 Activation-A recent study involving human cathepsin B has indicated its role in activation of latent TGF-␤1 in the human breast epithelial cell line (22) . To determine whether Leishmania cathepsin B had any effect on TGF-␤1 processing and activation in vitro, an immunoenzymatic assay using a cell-free incubation method was followed. TGF-␤1 activation was detected by Western blot analysis using antibodies specific for latent TGF-␤1 and mature-TGF-␤1. As shown in Fig. 7 , lane 1, latent TGF-␤1 is used as a negative control. Acid activation of TGF-␤1 resulted in the cleavage of latent TGF-␤1 into its pro and mature form (Fig. 7,  lane 2) , which is a positive control for our studies. The recombinant cathepsin B-JHE fusion protein also cleaved latent TGF-␤1 into the proregion and mature TGF-␤1 (Fig. 7, lane 3) , and when the cathepsin B-specific inhibitor, CA074, was included in the reaction, the cleavage activity was abolished (Fig.  7, lane 4) . Since cathepsin B was fused with JHE, JHE protein alone was used as a control, which did not show any cleaving activity (Fig. 7, lanes 5 and 6) . We have also used previously characterized cathepsin L-JHE fusion protein (23) , which failed to cleave the latent TGF-␤1 (Fig. 7, lanes 7 and 8) . In addition, latent TGF-␤1 was also cleaved by Leishmania whole cell lysates (Fig. 7, lane 9) . However, lysates from parasites treated with cathepsin B inhibitor, CA074, showed no cleavage (Fig. 7,  lane 10) , confirming that the activity seen in the Leishmania whole cell lysate was due to cathepsin B. We then used the parasite lysates from the transfectants expressing sense and antisense cathepsin B mRNA, to see the effect on TGF-␤1 cleavage. The results show that there was reduction in cleavage in case of transfectants expressing cathepsin B antisense mRNA (Fig. 7, lane 13) , compared with cathepsin B sense transfectants or vector alone (Fig. 7, lanes 11 and 12) , which further confirms that cathepsin B is responsible for the TGF-␤1 cleavage. Taken together, all the above results clearly demonstrate that Leishmania cathepsin B processed latent TGF-␤1 into its mature and proregion.
To detect the biological activity of TGF-␤1 in samples obtained from the enzymatic assay using latent TGF-␤1 and cathepsin B, mink lung epithelial cell growth inhibition assay was used. The values of incorporated thymidine are converted into percentage of DNA synthesized (Fig. 8) . The data suggest that latent TGF-␤1-treated cells had 94% of DNA synthesis. When the cells were treated with the acid-activated latent TGF-␤1, there was a 95% inhibition in DNA synthesis, indicating that there was maximum activation of latent TGF-␤1 into mature form. Similar results were obtained from the cells treated with latent TGF-␤1 incubated with cathepsin B-JHE fusion protein, although the percent of inhibition (60%) was less than that of acid-activated TGF-␤1. This may be attributed to the amount of active TGF-␤1 resulting from the activation by the amount of cathepsin B present in the cathepsin B-JHE fusion. However, this reduction was significant, when compared with that obtained from inhibitor treated cathepsin BJhe fusion (14% inhibition) as well as the JHE alone (5%) and JHE treated with inhibitor (6%). Cells treated with latent TGF-␤1 activated by Leishmania whole cell lysates also showed a significant reduction in DNA synthesis (72% inhibition) when compared with that of the inhibitor-treated whole cell lysates (22% inhibition). These results clearly indicate that Leishmania cathepsin B cleaves latent TGF-␤1 into mature and biologically active form of TGF-␤1, a function that has been shown for the first time in the case of Leishmania cathepsin B.
DISCUSSION
Cysteine proteases have been identified from different species of trypanosomatids including Leishmania (4, 25) and Trypanosoma (26) . We have previously reported the characterization and gene organization of cathepsin L-like cysteine proteases from the L. donovani complex (23) . In the present study, we have isolated and examined the functional significance of a cathepsin B-like gene from L. donovani and L. chagasi. Our results demonstrate that the cathepsin B-like gene is present as a single copy, expressed during all the life cycle stages of the parasite. Functional studies revealed that cathepsin B gene expression is important for the parasite sur- vival within the host macrophages. Also, for the first time, we have demonstrated that the recombinant cathepsin B protein as well as Leishmania whole cell lysates cleaved the latent human recombinant TGF-␤1 into the mature and biologically active form of TGF-␤1. Our results strongly suggest that cathepsin B plays an important role in the survival of Leishmania parasites within the host macrophages by activating latent TGF-␤.
The gene organization of L. chagasi and L. donovani cathepsin B indicates that it is a single copy gene, which is constitutively expressed at all stages of the parasite life cycle, with a transcript size of 2.4 kb. As the substrates used to detect the enzyme activity in leishmanial cell lysates are not totally specific to this class of cysteine protease, it is not possible to exactly correlate the levels of mRNA with that of enzyme activity in different life cycle stages. Sequence analysis showed that they are 90% identical to L. major CatB, 66% identical to L. mexicana cathepsin B, and only 45% identical to human cathepsin B, indicating high sequence conservation among the trypanosomatid species. Similar to that of L. major enzyme, L. chagasi and L. donovani cathepsin B have a glycine at residue 234, in the S2 subsite, which is known to account for the proteolytic activity with the peptide substrate, Z-Phe-Arg-AMC (27) . The recombinant cathepsin B-JHE fusion protein was proteolytically active, and it readily cleaved peptide substrate Z-Phe-Arg-AMC, but showed weaker activity toward Z-Arg-Arg-AMC (data not shown).
The functional role of cathepsin B on growth and survival of parasites was studied using a cathepsin B-specific, synthetic inhibitor CA074. The inhibitor did not have a direct cytotoxic effect on the parasite growth itself, but it greatly reduced the parasite survival within the U937 macrophages, suggesting that cathepsin B activity is necessary for the parasite survival as amastigotes within the host. The partial but not complete effect on macrophage infection in this case may be due to the inefficiency of cell permeability of CA074. In the present study, we have also used antisense RNA inhibition, to study the functional role of cathepsin B in the survival of L. donovani parasites. Transfection of plasmid constructs encoding antisense RNA has been used as an efficient tool for down-regulation of the gene expression in many protozoans (28) . We were able to significantly reduce cathepsin B gene expression, both at the mRNA and protein levels. As a result, we have noticed a reduction in parasite survival within the macrophages, which was consistent with that of the inhibitor studies. However, the reduction in parasite survival was not completely affected, which may be attributed to the redundant activity of other proteases like cathepsin L. Similar results were obtained in case of L. mexicana cpc (cathepsin B) null mutants, wherein the null mutants infected fewer peritoneal exudate cells than did the wild type parasites, confirming that cathepsin B does indeed play some part in the mammalian infective stages of the parasite (29) . Results from this study, as well as that of others (6, 29) , show that cathepsin B plays a role in enabling Leishmania to live within the macrophages. On the other hand, studies on cathepsin L-like cysteine proteases (cpb) null mutants have implicated cpb genes in being a virulence factor (30) . Therefore, it appears that the two cysteine proteases may have different roles in the parasite.
Studies involving some species of Leishmania such as L. major and L. amazonensis have been shown to induce the production of biologically active TGF-␤ by macrophages (7) . TGF-␤ prevents macrophage activation and exacerbates Leishmania infections. Susceptibility to L. chagasi infection in BALB/c mice is correlated with the localized production of TGF-␤ at the site of maximal parasite growth in the liver (8) .
TGF-␤ is also known to mediate a Th2-type cytokine response pattern. Studies involving cathepsin B-specific inhibitor, CA074, treatment in experimental murine leishmaniasis have indicated a switch of CD4ϩ T cell differentiation from Th2 to Th1, suggesting that cathepsin B plays a role in antigen processing and modulation of Th differentiation (6) . However, whether Leishmania cathepsin B will modulate Th differentiation remains to be shown. A recent study involving human cathepsin B has indicated its role in activation of latent TGF-␤ in human breast epithelial cell line (22) . In addition, the cathepsin B gene is known to be up-regulated by TGF-␤ treatment in vascular smooth muscle cells (31) . In this study, for the first time, we have shown with convincing evidence that Leishmania cathepsin B can cleave latent TGF-␤1 into biologically active form, using the recombinant protein as well as parasite whole cell lysate, in a cell-free system. This activity was completely inhibited in the presence of the cathepsin B-specific inhibitor CA074. This function can very well be correlated with the reduced survival of inhibitor treated as well as antisense RNA expressing parasites within the macrophage cells.
Pathogen-mediated activation of pre-existing pools of TGF-␤ has been reported in case of influenza virus neuraminidase (32) . Similarly, thrombospondin-1 homologues of Plasmodium spp. (33) and Cryptosporidium parvum (34) have been speculated to play a role in activating latent TGF-␤. Enhanced monocyte sialidase activity has been implicated to the activation of latent TGF-␤, in the case of Mycobacterium tuberculosis infection (16) . However, pathogen-mediated stimulation of the host's mechanism of TGF-␤ activation has not been clearly investigated so far. Our findings suggest that Leishmania cathepsin B might play a role in survival and pathogenesis by activating latent TGF-␤, thereby allowing the parasites to replicate within the macrophages. The mature and active TGF-␤ in turn suppresses Th1-type cytokine expression, causing susceptibility to disease (36) . TGF-␤ blocks IFN-␥-induced macrophage activation, including inhibition of inducible nitric-oxide synthase (35) and nitric oxide (24) production and thus enables the early replication of parasites within the macrophages. Our finding that cathepsin B can act as a TGF-␤-converting enzyme may contribute to the delineation of a new target for the interruption of these intracellular parasitic infections. We are currently attempting to obtain cathepsin B gene knock-outs, which can provide us with more knowledge in terms of its role in Leishmania pathogenesis using mouse models. Also, future studies will focus on the mechanism of activation of latent TGF-␤ by cathepsin B. These studies will add to the understanding of the complexity of the disease manifestation in case of intracellular parasites and may help define a new target for interventions of pathologies in which TGF-␤ is closely linked.
